# Eupraxia Pharmaceuticals Inc. (EPRX)

> Healthcare · CA · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/EPRX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -26.77M | $ -23.24M | $ 1.84M | $ 131.02M |
| 2025 | $ 0 | $ -39.50M | $ -28.67M | $ 154.4K | $ 82.04M |
| 2024 | $ 0 | $ -24.91M | $ -24.93M | $ 71.9K | $ 33.40M |
| 2023 | $ 0 | $ -29.61M | $ -21.09M | $ 7.87M | $ 1.67M |
| 2022 | $ 0 | $ -28.26M | $ -19.75M | $ 12.17M | $ 10.54M |
| 2021 | $ 0 | $ -21.66M | $ -18.14M | $ 9.99M | $ 19.95M |
| 2020 | $ 0 | $ -3.86M | $ -514.4K | $ 12.77M | $ -21.21M |
| 2019 | $ 0 | $ -2.51M | $ -1.05M | $ 11.94M | $ -17.69M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.08 |
| Current Ratio | 16.00 |

## Other views

- [Metrics](https://sponda.capital/en/EPRX.md)
- [Charts](https://sponda.capital/en/EPRX/charts.md)
- [Compare](https://sponda.capital/en/EPRX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.